Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota

Atherosclerosis (AS), especially atherosclerotic cardiovascular diseases (ASCVDs), and metabolic diseases (such as diabetes, obesity, dyslipidemia, and nonalcoholic fatty liver disease) are major public health issues worldwide that seriously threaten human health. Exploring effective natural product...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shengjie, Li, Dan, Yu, Zongliang, Li, Yujuan, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299362/
https://www.ncbi.nlm.nih.gov/pubmed/34305616
http://dx.doi.org/10.3389/fphar.2021.709629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299362/
https://www.ncbi.nlm.nih.gov/pubmed/34305616
http://dx.doi.org/10.3389/fphar.2021.709629

Ejemplares similares